Filing search / Kineta, Inc. / "Investigation"

8-K

EX-10.1

KANT Kineta, Inc.

8 Jul 24

Kineta Announces Exclusivity and Right of First Offer Agreement for its VISTA blocking antibody with TuHURA Biosciences

6:30am

investigation and evaluation of a Potential Transaction, and in the negotiation of such Definitive Agreements (unless otherwise set forth in such Definitive

8-K

EX-10.1

KANT Kineta, Inc.

29 Feb 24

Kineta Announces Restructuring and Exploration of Strategic Alternatives

7:00am

not to participate in, seek to recover in, or assist in any litigation or investigation by other persons or entities against the Released Parties, except as required … and any right to individual monetary recovery. However, nothing in this Agreement precludes you from initiating or participating in any investigation

8-K

EX-10.2

KANT Kineta, Inc.

29 Feb 24

Kineta Announces Restructuring and Exploration of Strategic Alternatives

7:00am

in, or assist in any litigation or investigation by other persons or entities against the Released Parties, except as required by law and/or otherwise … to individual monetary recovery. However, nothing in this Agreement precludes you from initiating or participating in any investigation or proceeding before any

8-K

EX-10.1

ycrbui7 b2uztbwg2d7

5 Oct 23

Kineta, Inc. Announces $3 Million Registered Direct Offering Priced At-The-Market under Nasdaq Rules

4:05pm

8-K

EX-10.1

ulp96i4

21 Apr 23

Kineta, Inc. Announces $6 Million Registered Direct Offering Priced At-The-Market under Nasdaq Rules

5:16pm

8-K

EX-99.5

1v63e7cr9

22 Dec 22

Kineta Completes Reverse Merger with Yumanity Therapeutics

5:02pm

8-K

EX-3.3

895 qv7ge0pp

22 Dec 22

Kineta Completes Reverse Merger with Yumanity Therapeutics

5:02pm

8-K

EX-10.17

br41sy c8

22 Dec 22

Kineta Completes Reverse Merger with Yumanity Therapeutics

5:02pm

8-K

EX-10.15

ro7q1zprp12s6h91ua

22 Dec 22

Kineta Completes Reverse Merger with Yumanity Therapeutics

5:02pm

8-K

EX-10.6

6fy xicmwn

22 Dec 22

Kineta Completes Reverse Merger with Yumanity Therapeutics

5:02pm

8-K

EX-99.6

3cgj5 0psqo

22 Dec 22

Kineta Completes Reverse Merger with Yumanity Therapeutics

5:02pm

8-K

EX-10.16

bzfef

22 Dec 22

Kineta Completes Reverse Merger with Yumanity Therapeutics

5:02pm

424B3

m8p zlhlfo6udcs

10 Nov 22

Prospectus supplement

4:21pm